Cel-Sci receives US patent to cover vaccine technology
This new patent follows research whcih showed that pretreatment and early therapy of experimental autoimmune myocarditis with a compound developed by Cel-Sci resulted in significant reduction in heart
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.